<DOC>
	<DOCNO>NCT00613899</DOCNO>
	<brief_summary>The investigator want test feasibility structure program telesurveillance home cough assistance ALS patient .</brief_summary>
	<brief_title>Feasibility Telesurveillance Home Cough Assistance Amyotrophic Lateral Patients ( ALS )</brief_title>
	<detailed_description>Background : Amyotrophic Lateral Sclerosis ( ALS ) patient present reduction inspiratory expiratory muscle strength , frequent secretion increase , insufficient expectoration ability inevitable risk acute respiratory failure ( ARF ) necessity hospitalization . Recently , new mechanical tool ( In-Exoflator EmersonR ) available hospital help patient expectorate ARF . It well note patient particularly reluctant hospitalize avoid worsen quality life . Aim : investigator want test feasibility structure program telesurveillance home cough assistance ALS patient . Methods : A telesurveillance program ( TP ) , pulse saturimetric device , 2 hour educational hospital section ( air stack Ambu balloon , manual manoeuvre In-Exoflator indication use ) offer ALS consecutive patient . In detail TP structure follow : 1 ) Domiciliary Telesurveillance one 24-h Service Centre ( SC ) enrol pts ALS hospital discharge phase , 2 ) Patients - take care five days/week nurse-tutor ( NT ) respiratory therapist ( RT ) accord predefined appointment , 3 ) 24-hr . duration ( case symptom ) patient call SC talk pneumologists intervene whenever need diagnostic-therapeutic adjustment . 4 ) In case need patient contact neurologist psychologist ; 5 ) The RT accordance pneumologist decide domiciliary visit patient . Home RT access In-Exoflator activation prescribe patient present worsen three point pSaTO2 , 30 % peak cough expiratory flow ( PCEF ) , lack cough ability increase secretion suction necessity ( tracheotomy patient ) clinical symptom ( dyspnoea , fever , headache , somnolence ) . Number In-Ex air stack activation , ARF episodes , hospital access , antibiotic therapy , customer satisfaction , PCF/PEF , MIC-VC , respiratory function ( MIP , MEP , FEV1 , FVC , FEV1/FVC , ABG ) , dyspnoea ( Borg scale ) , general disability ( Hoevelaken scale ALS Functional Rating Scale ) survival collect . Expected result : 30 ALS patient ( VC &lt; 80 % 40 % tracheotomy ) enrol discharge Respiratory Neurological unit S. Maugeri Foundation . This study allow : 1 . To test possible alternative care ALS patient 2 . To check patient caregiver ' acceptance 3 . To measure time consume care team 4 . To quantify patient 's comfort 5 . To test costs/effectiveness ratio .</detailed_description>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Inclusion criterion : 40 ALS patient ( VC &lt; 80 % without tracheostomy ) enrol discharge Respiratory Neurological unit S. Maugeri Foundation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>home care</keyword>
	<keyword>home rehabilitation</keyword>
	<keyword>telemedicine</keyword>
	<keyword>ALS</keyword>
</DOC>